These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20554749)

  • 1. FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women.
    Barnholtz-Sloan JS; Shetty PB; Guan X; Nyante SJ; Luo J; Brennan DJ; Millikan RC
    Carcinogenesis; 2010 Aug; 31(8):1417-23. PubMed ID: 20554749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States.
    Slattery ML; Baumgartner KB; Giuliano AR; Byers T; Herrick JS; Wolff RK
    Breast Cancer Res Treat; 2011 Sep; 129(2):531-9. PubMed ID: 21475998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.
    Jara L; Gonzalez-Hormazabal P; Cerceño K; Di Capua GA; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G
    Breast Cancer Res Treat; 2013 Jan; 137(2):559-69. PubMed ID: 23225170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.
    Rebbeck TR; DeMichele A; Tran TV; Panossian S; Bunin GR; Troxel AB; Strom BL
    Carcinogenesis; 2009 Feb; 30(2):269-74. PubMed ID: 19028704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India.
    Siddiqui S; Chattopadhyay S; Akhtar MS; Najm MZ; Deo SV; Shukla NK; Husain SA
    PLoS One; 2014; 9(10):e110426. PubMed ID: 25333473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication of breast cancer susceptibility loci in whites and African Americans using a Bayesian approach.
    O'Brien KM; Cole SR; Poole C; Bensen JT; Herring AH; Engel LS; Millikan RC
    Am J Epidemiol; 2014 Feb; 179(3):382-94. PubMed ID: 24218030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women.
    Mazhar A; Jamil F; Bashir Q; Ahmad MS; Masood M; Tanvir I; Rashid N; Waheed A; Afzal MN; Tariq MA
    Mol Med Rep; 2016 Oct; 14(4):3443-51. PubMed ID: 27572905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in second intron of the FGFR2 gene are associated with the risk of early-onset breast cancer in Chinese Han women.
    Fu F; Wang C; Huang M; Song C; Lin S; Huang H
    Tohoku J Exp Med; 2012 Mar; 226(3):221-9. PubMed ID: 22374580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis.
    Zhou L; Yao F; Luan H; Wang Y; Dong X; Zhou W; Wang Q
    Breast Cancer Res Treat; 2012 Dec; 136(3):885-97. PubMed ID: 23124475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.
    Chan M; Ji SM; Liaw CS; Yap YS; Law HY; Yoon CS; Wong CY; Yong WS; Wong NS; Ng R; Ong KW; Madhukumar P; Oey CL; Tan PH; Li HH; Ang P; Ho GH; Lee AS
    Breast Cancer Res Treat; 2012 Nov; 136(1):209-20. PubMed ID: 22965832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations.
    Raskin L; Pinchev M; Arad C; Lejbkowicz F; Tamir A; Rennert HS; Rennert G; Gruber SB
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1060-5. PubMed ID: 18483326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers.
    Zheng Y; Ogundiran TO; Falusi AG; Nathanson KL; John EM; Hennis AJ; Ambs S; Domchek SM; Rebbeck TR; Simon MS; Nemesure B; Wu SY; Leske MC; Odetunde A; Niu Q; Zhang J; Afolabi C; Gamazon ER; Cox NJ; Olopade CO; Olopade OI; Huo D
    Carcinogenesis; 2013 Jul; 34(7):1520-8. PubMed ID: 23475944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.
    Shan J; Mahfoudh W; Dsouza SP; Hassen E; Bouaouina N; Abdelhak S; Benhadjayed A; Memmi H; Mathew RA; Aigha II; Gabbouj S; Remadi Y; Chouchane L
    Breast Cancer Res Treat; 2012 Oct; 135(3):715-24. PubMed ID: 22910930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of Breast Cancer Associations with Common Genetic Variants in FGFR2 according to the Intrinsic Subtypes in Southern Han Chinese Women.
    Liang H; Yang X; Chen L; Li H; Zhu A; Sun M; Wang H; Li M
    Biomed Res Int; 2015; 2015():626948. PubMed ID: 26421298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation.
    Udler MS; Meyer KB; Pooley KA; Karlins E; Struewing JP; Zhang J; Doody DR; MacArthur S; Tyrer J; Pharoah PD; Luben R; Bernstein L; Kolonel LN; Henderson BE; Le Marchand L; Ursin G; Press MF; Brennan P; Sangrajrang S; Gaborieau V; Odefrey F; Shen CY; Wu PE; Wang HC; Kang D; Yoo KY; Noh DY; Ahn SH; Ponder BA; Haiman CA; Malone KE; Dunning AM; Ostrander EA; Easton DF;
    Hum Mol Genet; 2009 May; 18(9):1692-703. PubMed ID: 19223389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.
    Andersen SW; Trentham-Dietz A; Figueroa JD; Titus LJ; Cai Q; Long J; Hampton JM; Egan KM; Newcomb PA
    Menopause; 2013 Mar; 20(3):354-8. PubMed ID: 23435034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations.
    Barzan D; Veldwijk MR; Herskind C; Li Y; Zhang B; Sperk E; Du WD; Zhang XJ; Wenz F
    Eur J Hum Genet; 2013 Nov; 21(11):1286-92. PubMed ID: 23486537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry.
    Huo D; Zheng Y; Ogundiran TO; Adebamowo C; Nathanson KL; Domchek SM; Rebbeck TR; Simon MS; John EM; Hennis A; Nemesure B; Wu SY; Leske MC; Ambs S; Niu Q; Zhang J; Cox NJ; Olopade OI
    Carcinogenesis; 2012 Apr; 33(4):835-40. PubMed ID: 22357627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women.
    Liang J; Chen P; Hu Z; Zhou X; Chen L; Li M; Wang Y; Tang J; Wang H; Shen H
    Carcinogenesis; 2008 Dec; 29(12):2341-6. PubMed ID: 18845558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: results of a case control study in Japan.
    Kawase T; Matsuo K; Suzuki T; Hiraki A; Watanabe M; Iwata H; Tanaka H; Tajima K
    Int J Cancer; 2009 Oct; 125(8):1946-52. PubMed ID: 19582883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.